Education
About Us
Working with TipRanks
Follow Us
Coelho Peev, Cristiane Zanqueta Insider Profile
4 Followers
Coelho Peev, Cristiane Zanqueta, Senior Officer at Knight Therapeutics, holds 6.07K shares in Knight Therapeutics (Ticker: KHTRF).
Coelho Peev, Cristiane Zanqueta has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Coelho Peev, Cristiane Zanqueta's holdings
Insider Roles
Senior Officer
Roles that Coelho Peev, Cristiane Zanqueta holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Coelho Peev, Cristiane Zanqueta
Coelho Peev, Cristiane Zanqueta's Trading History
List of latest transactions for each holding click on a transaction to see Coelho Peev, Cristiane Zanqueta's performance on stock
You May Also Like
Coelho Peev, Cristiane Zanqueta insider profile FAQ
What is the percentage of profitable transactions made by Coelho Peev, Cristiane Zanqueta?
The percentage of profitable transactions made by Coelho Peev, Cristiane Zanqueta is ―.
What is the average return per transaction made by Coelho Peev, Cristiane Zanqueta?
The average return per transaction made by Coelho Peev, Cristiane Zanqueta is ―.
What stocks does Coelho Peev, Cristiane Zanqueta hold?
Coelho Peev, Cristiane Zanqueta holds: KHTRF stocks.
What was Coelho Peev, Cristiane Zanqueta’s latest transaction?
Coelho Peev, Cristiane Zanqueta latest transaction was an Uninformative Buy of $5.55K.
What was Coelho Peev, Cristiane Zanqueta's most profitable transaction?
Coelho Peev, Cristiane Zanqueta’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Coelho Peev, Cristiane Zanqueta's role in Knight Therapeutics?
Coelho Peev, Cristiane Zanqueta's role in Knight Therapeutics is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.